{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:46:47Z","timestamp":1793213207301,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00198-025-07661-4","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T21:21:28Z","timestamp":1755897688000},"page":"2353-2379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"HyungSub","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyungJu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Soo","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Hwan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sub-Ri","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namhoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Won","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4880-5310","authenticated-orcid":false,"given":"Ji-Won","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"7661_CR1","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 285(6):785\u2013795","DOI":"10.1001\/jama.285.6.785"},{"issue":"6","key":"7661_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/joim.12369","volume":"277","author":"M Lorentzon","year":"2015","unstructured":"Lorentzon M, Cummings SR (2015) Osteoporosis: the evolution of a diagnosis. J Intern Med 277(6):650\u2013661","journal-title":"J Intern Med"},{"issue":"5","key":"7661_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00198-017-3909-3","volume":"28","author":"G Ballane","year":"2017","unstructured":"Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G (2017) Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int 28(5):1531\u20131542","journal-title":"Osteoporos Int"},{"issue":"7","key":"7661_CR4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1359\/jbmr.2003.18.7.1254","volume":"18","author":"T Jalava","year":"2003","unstructured":"Jalava T, Sarna S, Pylkk\u00e4nen L et al (2003) Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res 18(7):1254\u20131260","journal-title":"J Bone Miner Res"},{"issue":"7","key":"7661_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s001980070075","volume":"11","author":"JA Cauley","year":"2000","unstructured":"Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11(7):556\u2013561","journal-title":"Osteoporos Int"},{"issue":"10","key":"7661_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","volume":"128","author":"MC Nevitt","year":"1998","unstructured":"Nevitt MC, Ettinger B, Black DM et al (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128(10):793\u2013800","journal-title":"Ann Intern Med"},{"issue":"12","key":"7661_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s001980170015","volume":"12","author":"AN Tosteson","year":"2001","unstructured":"Tosteson AN, Gabriel SE, Grove MR, Moncur MM, Kneeland TS, Melton LJ 3rd (2001) Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 12(12):1042\u20131049","journal-title":"Osteoporos Int"},{"issue":"2","key":"7661_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF03324588","volume":"17","author":"JD Adachi","year":"2005","unstructured":"Adachi JD, Rizzoli R, Boonen S, Li Z, Meredith MP, Chesnut CH 3rd (2005) Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data. Aging Clin Exp Res 17(2):150\u2013156","journal-title":"Aging Clin Exp Res"},{"issue":"24","key":"7661_CR9","first-page":"3911","volume":"24","author":"KM Li","year":"2020","unstructured":"Li KM, Zhu LG, Zhang Q et al (2020) Zolidronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fractures: A meta-analysis of bone density improvement, recurrent vertebral fractures prevention, and long-term efficacy evaluation. Chinese Journal of Tissue Engineering Research 24(24):3911\u20133917","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"7661_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.wneu.2021.09.131","volume":"157","author":"B Tang","year":"2022","unstructured":"Tang B, Zeng H, Hu S, Liu K, Wu L, Shi X (2022) Percutaneous vertebroplasty combined with zoledronic acid in treatment and prevention of osteoporotic vertebral compression fractures: a systematic review and meta-analysis of comparative studies. World Neurosurg 157:75\u201387","journal-title":"World Neurosurg"},{"issue":"Suppl 1","key":"7661_CR11","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jfma.2023.04.004","volume":"122","author":"TW Tai","year":"2023","unstructured":"Tai TW, Tsai YL, Shih CA et al (2023) Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter. J Formos Med Assoc 122(Suppl 1):S65\u2013S73","journal-title":"J Formos Med Assoc"},{"key":"7661_CR12","doi-asserted-by":"crossref","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721\u2013739","DOI":"10.1359\/jbmr.2000.15.4.721"},{"key":"7661_CR13","doi-asserted-by":"crossref","unstructured":"Lee SB, Park Y, Kim DW et al (2021) Association between mortality risk and the number, location, and sequence of subsequent fractures in the elderly. Osteoporos Int 32(2):233\u2013241","DOI":"10.1007\/s00198-020-05602-x"},{"issue":"3","key":"7661_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.spinee.2018.08.004","volume":"19","author":"DW Barton","year":"2019","unstructured":"Barton DW, Behrend CJ, Carmouche JJ (2019) Rates of osteoporosis screening and treatment following vertebral fracture. Spine J 19(3):411\u2013417","journal-title":"Spine J"},{"issue":"1","key":"7661_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-017-0317-4","volume":"12","author":"J Flais","year":"2017","unstructured":"Flais J, Coiffier G, Le Noach J et al (2017) Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture. Arch Osteoporos 12(1):24","journal-title":"Arch Osteoporos"},{"issue":"Suppl 1","key":"7661_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update. Endocr Pract 26(Suppl 1):1\u201346","journal-title":"Endocr Pract"},{"key":"7661_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-105","volume":"12","author":"J Panula","year":"2011","unstructured":"Panula J, Pihlajam\u00e4ki H, Mattila VM et al (2011) Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord 12:105","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"7661_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00198-015-3277-9","volume":"27","author":"J Leal","year":"2016","unstructured":"Leal J, Gray AM, Prieto-Alhambra D et al (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27(2):549\u2013558","journal-title":"Osteoporos Int"},{"key":"7661_CR19","doi-asserted-by":"crossref","unstructured":"Wells GA, Cranney A, Peterson J et al (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (1):CD001155","DOI":"10.1002\/14651858.CD001155.pub2"},{"key":"7661_CR20","doi-asserted-by":"crossref","unstructured":"Wells GA, Hsieh SC, Peterson J et al (2024) Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 4(4):CD003376","DOI":"10.1002\/14651858.CD003376.pub4"},{"issue":"5","key":"7661_CR21","volume":"5","author":"GA Wells","year":"2022","unstructured":"Wells GA, Hsieh SC, Zheng C, Peterson J, Tugwell P, Liu W (2022) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 5(5):CD004523","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"7661_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.5435\/JAAOS-D-23-00932","volume":"32","author":"AM Liu","year":"2024","unstructured":"Liu AM, Mirle V, Lee C, Hynes K, Dirschl DR, Strelzow J (2024) Forgetting the frail: national trends in vitamin D prescription after fragility fracture-a large insurance claims database study. J Am Acad Orthop Surg 32(10):464\u2013471","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"7661_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1302\/0301-620X.97B1.34558","volume":"97-B","author":"GS Maier","year":"2015","unstructured":"Maier GS, Seeger JB, Horas K, Roth KE, Kurth AA, Maus U (2015) The prevalence of vitamin D deficiency in patients with vertebral fragility fractures. Bone Jt J 97-B(1):89\u201393","journal-title":"Bone Jt J"},{"key":"7661_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"7661_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"7661_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"issue":"7109","key":"7661_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"4","key":"7661_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, Rucker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153\u2013160","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"7661_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods 12(1):55\u201361","journal-title":"Res Synth Methods"},{"issue":"22","key":"7661_CR30","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1001\/archinte.1997.00440430099012","volume":"157","author":"KE Ensrud","year":"1997","unstructured":"Ensrud KE, Black DM, Palermo L et al (1997) Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med 157(22):2617\u20132624","journal-title":"Arch Intern Med"},{"issue":"5","key":"7661_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00198-004-1698-y","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Barton IP, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16(5):475\u2013482","journal-title":"Osteoporos Int"},{"issue":"4","key":"7661_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1185\/030079903125003125","volume":"20","author":"C Roux","year":"2004","unstructured":"Roux C, Seeman E, Eastell R et al (2004) Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 20(4):433\u2013439","journal-title":"Curr Med Res Opin"},{"key":"7661_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60081314","author":"BT Kwon","year":"2024","unstructured":"Kwon BT, Ham DW, Park SM, Kim HJ, Yeom JS (2024) Impact of teriparatide and denosumab on clinical and radiographic outcomes in osteoporotic vertebral compression fractures. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina60081314","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"7661_CR34","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1210\/jc.2013-4175","volume":"99","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Matsumoto T, Sugimoto T et al (2014) Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab 99(7):2599\u20132607","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"7661_CR35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00198-020-05816-z","volume":"32","author":"K Lu","year":"2021","unstructured":"Lu K, Yin Y, Li C, Jin Y, Shan HQ (2021) Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study. Osteoporos Int 32(7):1429\u20131439","journal-title":"Osteoporos Int"},{"issue":"8","key":"7661_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00198-008-0816-7","volume":"20","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Hagino H, Shiraki M et al (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20(8):1429\u20131437","journal-title":"Osteoporos Int"},{"key":"7661_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2019.100217","volume":"11","author":"K Shigenobu","year":"2019","unstructured":"Shigenobu K, Hashimoto T, Kanayama M, Ohha H, Yamane S (2019) The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - in comparison with weekly teriparatide with bisphosphonate. Bone Rep 11:100217","journal-title":"Bone Rep"},{"key":"7661_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13072040","author":"S Son","year":"2024","unstructured":"Son S, Oh MY, Yoo BR, Park HB (2024) Comparison of the efficacy of zoledronate and denosumab in patients with acute osteoporotic vertebral compression fractures: a randomized controlled trial. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13072040","journal-title":"J Clin Med"},{"issue":"1","key":"7661_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11657-024-01374-7","volume":"19","author":"M Ueno","year":"2024","unstructured":"Ueno M, Tajima Y, Ito S et al (2024) Comparative analysis of anti-osteoporosis medications in preventing vertebral body fractures after balloon kyphoplasty. Arch Osteoporos 19(1):19","journal-title":"Arch Osteoporos"},{"issue":"1","key":"7661_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziae137","volume":"9","author":"H Inose","year":"2025","unstructured":"Inose H, Takahashi S, Teraguchi M et al (2025) Romosozumab versus bisphosphonates for preventing subsequent vertebral fractures after balloon kyphoplasty: comparison using data from two prospective multicenter studies. JBMR Plus 9(1):ziae137","journal-title":"JBMR Plus"},{"key":"7661_CR41","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/CIA.S224663","volume":"14","author":"M Kong","year":"2019","unstructured":"Kong M, Zhou C, Zhu K et al (2019) 12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women. Clin Interv Aging 14:1693\u20131703","journal-title":"Clin Interv Aging"},{"issue":"3","key":"7661_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s40520-023-02342-w","volume":"35","author":"D Yang","year":"2023","unstructured":"Yang D, Tan J, Long Y et al (2023) Sequential treatment of teriparatide and alendronate versus alendronate alone for elevation of bone mineral density and prevention of refracture after percutaneous vertebroplasty in osteoporosis: a prospective study. Aging Clin Exp Res 35(3):531\u2013539","journal-title":"Aging Clin Exp Res"},{"issue":"9041","key":"7661_CR43","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Fracture Intervention Trial Research Group et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348(9041):1535\u20131541","journal-title":"Lancet"},{"issue":"6","key":"7661_CR44","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1359\/jbmr.2002.17.6.1057","volume":"17","author":"C Brumsen","year":"2002","unstructured":"Brumsen C, Papapoulos SE, Lips P et al (2002) Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension. J Bone Miner Res 17(6):1057\u20131064","journal-title":"J Bone Miner Res"},{"key":"7661_CR45","doi-asserted-by":"crossref","unstructured":"Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282(14):1344\u20131352","DOI":"10.1001\/jama.282.14.1344"},{"key":"7661_CR46","doi-asserted-by":"publisher","first-page":"8039671","DOI":"10.1155\/2020\/8039671","volume":"2020","author":"W Hu","year":"2020","unstructured":"Hu W, Wang H, Shi X et al (2020) Effect of Preoperative Zoledronic Acid Administration on Pain Intensity after Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures. Pain Res Manag 2020:8039671","journal-title":"Pain Res Manag"},{"issue":"1","key":"7661_CR47","first-page":"63","volume":"22","author":"ZF Huang","year":"2019","unstructured":"Huang ZF, Xiao SX, Liu K, Xiong W (2019) Effectiveness analysis of percutaneous kyphoplasty combined with zoledronic acid in treatment of primary osteoporotic vertebral compression fractures. Pain Physician 22(1):63\u201368","journal-title":"Pain Physician"},{"issue":"5","key":"7661_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/08941939.2017.1339151","volume":"31","author":"B Liu","year":"2018","unstructured":"Liu B, Gan F, Ge Y, Yu H (2018) Clinical efficacy analysis of percutaneous kyphoplasty combined with zoledronic acid in the treatment and prevention of osteoporotic vertebral compression fractures. J Invest Surg 31(5):425\u2013430","journal-title":"J Invest Surg"},{"issue":"7","key":"7661_CR49","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s00402-022-04557-4","volume":"143","author":"K Liu","year":"2023","unstructured":"Liu K, Tan G, Sun W, Lu Q, Tang J, Yu D (2023) Percutaneous kyphoplasty combined with zoledronic acid for the treatment of primary osteoporotic vertebral compression fracture: a prospective, multicenter study. Arch Orthop Trauma Surg 143(7):3699\u20133706","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"7661_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"J Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, Vertebral Efficacy with Risedronate Therapy (VERT) Study Group et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11(1):83\u201391","journal-title":"Osteoporos Int"},{"key":"7661_CR51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2147\/CIA.S146871","volume":"13","author":"C Shi","year":"2018","unstructured":"Shi C, Zhang M, Cheng AY, Huang ZF (2018) Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly. Clin Interv Aging 13:853\u2013861","journal-title":"Clin Interv Aging"},{"issue":"2","key":"7661_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"NB Watts","year":"1990","unstructured":"Watts NB, Harris ST, Genant HK et al (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323(2):73\u201379","journal-title":"N Engl J Med"},{"issue":"12","key":"7661_CR53","first-page":"340","volume":"30","author":"W Wu","year":"2024","unstructured":"Wu W, Zheng W, Pan W, Chen F, Jiang L (2024) Reducing re-fractures post percutaneous kyphoplasty: the impact of zoledronic acid with calcium and vitamin D3 in osteoporotic patients. Altern Ther Health Med 30(12):340\u2013345","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"7661_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.23736\/S0390-5616.20.05117-6","volume":"68","author":"H Yi","year":"2024","unstructured":"Yi H, Chen T, Gan J et al (2024) Effects of percutaneous kyphoplasty combined with zoledronic acid injection on osteoporotic vertebral compression fracture and bone metabolism indices. J Neurosurg Sci 68(1):80\u201388","journal-title":"J Neurosurg Sci"},{"issue":"7","key":"7661_CR55","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00198-019-04896-w","volume":"30","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang T, Xu X, Cai Q, Zhao D (2019) Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women. Osteoporos Int 30(7):1475\u20131480","journal-title":"Osteoporos Int"},{"key":"7661_CR56","doi-asserted-by":"publisher","DOI":"10.1177\/21925682241265327","author":"VV Nair","year":"2024","unstructured":"Nair VV, Kundnani V (2024) Does early treatment with teriparatide prevent the need for surgical intervention in osteoporotic vertebral compression fractures. Glob Spine J. https:\/\/doi.org\/10.1177\/21925682241265327","journal-title":"Glob Spine J"},{"issue":"9","key":"7661_CR57","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1210\/jc.2011-3479","volume":"97","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Sugimoto T, Nakano T et al (2012) Randomized teriparatide [human parathyroid hormone (PTH) 1\u201334] once-weekly efficacy research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 97(9):3097\u20133106","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7661_CR58","doi-asserted-by":"publisher","first-page":"611","DOI":"10.31616\/asj.2020.0282","volume":"15","author":"J Zhang","year":"2021","unstructured":"Zhang J, Yan B, Chen Z, Zheng Z, Yang C (2021) Risk of new vertebral fracture and combination therapy with zoledronic acid and teriparatide in diabetic patients after percutaneous kyphoplasty. Asian Spine J 15(5):611\u2013617","journal-title":"Asian Spine J"},{"issue":"8","key":"7661_CR59","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s00198-011-1856-y","volume":"23","author":"P Hadji","year":"2012","unstructured":"Hadji P, Zanchetta JR, Russo L et al (2012) The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporos Int 23(8):2141\u20132150","journal-title":"Osteoporos Int"},{"issue":"10117","key":"7661_CR60","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","volume":"391","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Marin F, Zerbini CAF et al (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391(10117):230\u2013240","journal-title":"Lancet"},{"key":"7661_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101762","volume":"21","author":"K Maruo","year":"2024","unstructured":"Maruo K, Kusukawa T, Toi M et al (2024) Comparison of osteoanabolic agents (teriparatide and romosozumab) with bisphosphonates in prevention of subsequent vertebral fractures in patients treated for osteoporotic vertebral fracture for 12 months: an observational cohort study. Bone Rep 21:101762","journal-title":"Bone Rep"},{"issue":"2","key":"7661_CR62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.31616\/asj.2018.0098","volume":"13","author":"K Maruo","year":"2019","unstructured":"Maruo K, Tachibana T, Arizumi F, Kusuyama K, Kishima K, Yoshiya S (2019) Effect of teriparatide on subsequent vertebral fractures after instrumented fusion surgery for osteoporotic vertebral fractures with neurological deficits. Asian Spine J 13(2):283\u2013289","journal-title":"Asian Spine J"},{"issue":"1","key":"7661_CR63","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00774-014-0646-y","volume":"34","author":"H Tsuchie","year":"2016","unstructured":"Tsuchie H, Miyakoshi N, Kasukawa Y et al (2016) The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture. J Bone Miner Metab 34(1):86\u201391","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"7661_CR64","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s00198-016-3651-2","volume":"27","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Xue R, Shi N et al (2016) Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications. Osteoporos Int 27(11):3309\u20133317","journal-title":"Osteoporos Int"},{"issue":"7","key":"7661_CR65","doi-asserted-by":"publisher","first-page":"261","DOI":"10.36478\/makrjms.2024.7.261.266","volume":"18","author":"NK Bava","year":"2024","unstructured":"Bava NK, Mohammed ZH, Annamalai TT, Mathew KC, Sheriff M (2024) Is vitamin-D supplementation has effect in the functional outcome of osteoporotic vertebral fractures. Res J Med Sci 18(7):261\u2013266","journal-title":"Res J Med Sci"},{"issue":"1","key":"7661_CR66","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s13018-021-02717-7","volume":"16","author":"S Ko","year":"2021","unstructured":"Ko S, Jun C, Nam J (2021) Effects of vitamin D supplementation on the functional outcome in patients with osteoporotic vertebral compression fracture and vitamin D deficiency. J Orthop Surg Res 16(1):571","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"7661_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1509-1","volume":"18","author":"A Iwata","year":"2017","unstructured":"Iwata A, Kanayama M, Oha F, Hashimoto T, Iwasaki N (2017) Effect of teriparatide (rh-PTH 1\u201334) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: a retrospective comparative study. BMC Musculoskelet Disord 18(1):148","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"7661_CR68","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.31616\/asj.2023.0109","volume":"17","author":"VV Nair","year":"2023","unstructured":"Nair VV, Kundnani V, Shetty A, Anand M, Jain M, Dewnany N (2023) Is teriparatide superior in treating osteoporotic vertebral compression fractures in comparison to bisphosphonates treatment alone: a 2-year retrospective analysis. Asian Spine J 17(6):1098\u20131107","journal-title":"Asian Spine J"},{"issue":"15","key":"7661_CR69","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018964","volume":"99","author":"G Fan","year":"2020","unstructured":"Fan G, Zhao Q, Lu P et al (2020) Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: a meta-analysis. Medicine (Baltimore) 99(15):e18964","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"7661_CR70","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024839","volume":"100","author":"Y Ouyang","year":"2021","unstructured":"Ouyang Y, Chen S, Wan T, Zheng G, Sun G (2021) The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 100(7):e24839","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"7661_CR71","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3171\/2021.5.SPINE202003","volume":"36","author":"K Sawakami","year":"2022","unstructured":"Sawakami K, Watanabe K, Hasegawa K et al (2022) Neoadjuvant teriparatide therapy targeting the osteoporotic spine: influence of administration period from the perspective of bone histomorphometry. J Neurosurg Spine 36(3):429\u2013439","journal-title":"J Neurosurg Spine"},{"issue":"2","key":"7661_CR72","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-17-0920","volume":"178","author":"E Canalis","year":"2018","unstructured":"Canalis E (2018) Management of endocrine disease: novel anabolic treatments for osteoporosis. Eur J Endocrinol 178(2):R33\u2013R44","journal-title":"Eur J Endocrinol"},{"issue":"10102","key":"7661_CR73","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","volume":"390","author":"BL Langdahl","year":"2017","unstructured":"Langdahl BL, Libanati C, Crittenden DB et al (2017) Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet 390(10102):1585\u20131594","journal-title":"Lancet"},{"issue":"1","key":"7661_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jbmr.173","volume":"26","author":"D Padhi","year":"2011","unstructured":"Padhi D, Jang G, Stouch B, Fang L, Posvar E (2011) Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26(1):19\u201326","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7661_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/jsp2.1356","volume":"7","author":"K Ishikawa","year":"2024","unstructured":"Ishikawa K, Tani S, Toyone T et al (2024) The potential effect of romosozumab on perioperative management for instrumentation surgery. JOR Spine 7(3):e1356","journal-title":"JOR Spine"},{"issue":"7","key":"7661_CR76","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/jbmr.3996","volume":"35","author":"F Cosman","year":"2020","unstructured":"Cosman F, Lewiecki EM, Ebeling PR et al (2020) T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial. J Bone Miner Res 35(7):1333\u20131342","journal-title":"J Bone Miner Res"},{"issue":"4","key":"7661_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvir.2020.100701","volume":"23","author":"AE Bravo","year":"2020","unstructured":"Bravo AE, Brasuell JE, Favre AW, Koenig BM, Khan AA, Beall DP (2020) Treating vertebral compression fractures: establishing the appropriate diagnosis, preoperative considerations, treatment techniques, postoperative follow-up and general guidelines for the treatment of patients with symptomatic vertebral compression fractures. Tech Vasc Interv Radiol 23(4):100701","journal-title":"Tech Vasc Interv Radiol"},{"issue":"46","key":"7661_CR78","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035749","volume":"102","author":"Z Qiu","year":"2023","unstructured":"Qiu Z, Wang P, Chao Y, Yu Y (2023) The risk of new vertebral fracture after percutaneous vertebral augmentation in patients suffering from single-level osteoporotic vertebral compression fractures: a meta-analysis and systematic review. Medicine (Baltimore) 102(46):e35749","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"7661_CR79","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10815","volume":"22","author":"B Kim","year":"2021","unstructured":"Kim B, Cho YJ, Lim W (2021) Osteoporosis therapies and their mechanisms of action (review). Exp Ther Med 22(6):1379","journal-title":"Exp Ther Med"},{"issue":"3","key":"7661_CR80","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tem.2015.01.004","volume":"26","author":"M Pazianas","year":"2015","unstructured":"Pazianas M (2015) Anabolic effects of PTH and the \u201canabolic window.\u201d Trends Endocrinol Metab 26(3):111\u2013113","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"7661_CR81","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL et al (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10(10):1478\u20131487","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7661_CR82","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/jbmr.5650110203","volume":"11","author":"AM Parfitt","year":"1996","unstructured":"Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF (1996) A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res 11(2):150\u2013159","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7661_CR83","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jbmr.3194","volume":"33","author":"DM Black","year":"2018","unstructured":"Black DM, Cauley JA, Wagman R et al (2018) The ability of a single BMD and fracture history assessment to predict fracture over 25 years in postmenopausal women: the study of osteoporotic fractures. J Bone Miner Res 33(3):389\u2013395","journal-title":"J Bone Miner Res"},{"issue":"7041","key":"7661_CR84","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254\u20131259","journal-title":"BMJ"},{"issue":"5","key":"7661_CR85","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00198-021-06264-z","volume":"33","author":"H Iida","year":"2022","unstructured":"Iida H, Sakai Y, Seki T et al (2022) Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture. Osteoporos Int 33(5):1147\u20131154","journal-title":"Osteoporos Int"},{"issue":"49","key":"7661_CR86","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032018","volume":"101","author":"SS Choi","year":"2022","unstructured":"Choi SS, Kim H, Choung YJ, Jeong SJ, Lee CH (2022) Risk factors for new vertebral compression fracture after kyphoplasty and efficacy of osteoporosis treatment: a STROBE-compliant retrospective study. Medicine (Baltimore) 101(49):e32018","journal-title":"Medicine (Baltimore)"},{"issue":"47","key":"7661_CR87","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035042","volume":"102","author":"S Park","year":"2023","unstructured":"Park S, Sik Choi S, Kim H, Yoon Byun S, Lee CH (2023) Risk factors for new vertebral compression fracture after vertebroplasty and efficacy of osteoporosis treatment: A STROBE-compliant retrospective study. Medicine (Baltimore) 102(47):e35042","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"7661_CR88","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00586-013-3110-0","volume":"23","author":"G Sun","year":"2014","unstructured":"Sun G, Tang H, Li M, Liu X, Jin P, Li L (2014) Analysis of risk factors of subsequent fractures after vertebroplasty. Eur Spine J 23(6):1339\u20131345","journal-title":"Eur Spine J"},{"issue":"4","key":"7661_CR89","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1152\/japplphysiol.00290.2009","volume":"107","author":"C Suetta","year":"2009","unstructured":"Suetta C, Hvid LG, Justesen L et al (2009) Effects of aging on human skeletal muscle after immobilization and retraining. J Appl Physiol 107(4):1172\u20131180","journal-title":"J Appl Physiol"},{"issue":"1","key":"7661_CR90","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1152\/jappl.1997.82.1.182","volume":"82","author":"HE Berg","year":"1997","unstructured":"Berg HE, Larsson L, Tesch PA (1997) Lower limb skeletal muscle function after 6 wk of bed rest. J Appl Physiol 82(1):182\u2013188","journal-title":"J Appl Physiol"},{"issue":"3","key":"7661_CR91","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jcsm.12411","volume":"10","author":"SSY Yeung","year":"2019","unstructured":"Yeung SSY, Reijnierse EM, Pham VK et al (2019) Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 10(3):485\u2013500","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"7661_CR92","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12891-024-07295-3","volume":"25","author":"C Jing","year":"2024","unstructured":"Jing C, Wang H, Liu P et al (2024) Effect of sarcopenia on refractures of adjacent vertebra after percutaneous kyphoplasty. BMC Musculoskelet Disord 25(1):210","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"7661_CR93","doi-asserted-by":"publisher","first-page":"537S","DOI":"10.1093\/ajcn\/88.2.537S","volume":"88","author":"B Dawson-Hughes","year":"2008","unstructured":"Dawson-Hughes B (2008) Serum 25-hydroxyvitamin D and functional outcomes in the elderly1. Am J Clin Nutr 88(2):537S-S540","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"7661_CR94","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1210\/clinem\/dgab742","volume":"107","author":"M Chakhtoura","year":"2022","unstructured":"Chakhtoura M, Bacha DS, Gharios C et al (2022) Vitamin D supplementation and fractures in adults: a systematic umbrella review of meta-analyses of controlled trials. J Clin Endocrinol Metab 107(3):882\u2013898","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7661_CR95","first-page":"120","volume":"6","author":"G Iolascon","year":"2009","unstructured":"Iolascon G, Di Pietro G, Gimigliano F (2009) Vitamin D supplementation in fractured patient: how, when and why. Clin Cases Miner Bone Metab 6(2):120\u2013124","journal-title":"Clin Cases Miner Bone Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07661-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:02:44Z","timestamp":1764687764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07661-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":95,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7661"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07661-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HyungSub Jin, HyungJu Jin, Kyung-Soo Suk, Byung Ho Lee, Si Young Park, Hak-Sun Kim, Seong-Hwan Moon, Sub-Ri Park, Namhoo Kim, Jae Won Shin, and Ji-Won Kwon declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}